Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Clin Immunol. 2012 Oct 7;145(3):209–223. doi: 10.1016/j.clim.2012.09.012

Figure 5.

Figure 5

Phenotypic characterization of CD4+CD25highCD127low/− Tregs in MG patients vs healthy controls. Cell staining was performed as described in “Materials and methods.” Representative flow cytometry plots and bar diagrams showing the percentage of CD45RA+ (A), CD31+ (B), CD45RO+ (C) Treg cell subsets; percentage of cells expressing HLA-DR (D) and CTLA-4 (E) in Tregs isolated from MG patients (n=14) and control subjects (n=14).